Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...
February 3, 2025 • Episode: 1324 C rations: Armies trying to travel on their stomachs. Today, an army tries to travel on its stomach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback